Visceral leishmaniasis: WHO publishes validation document as countries approach elimination

Patients treated for visceral leishmaniasis, Bangladesh
© Jonathan Torgovnik

11 November 2016 | New Delhi | Geneva –– Three countries that were once highly endemic for visceral leishmaniasis are poised to eliminate the disease as a public health problem by 2020.

Bangladesh, India and Nepal have lowered the number of new cases and as the three countries approach elimination, WHO's Regional Office for South-East Asia has published the process to validate the elimination of this form of leishmaniasis.

WHO and Gilead Sciences extend collaboration against visceral leishmaniasis

Treatment against visceral leishmaniasis, South Sudan
© J. A. Ruiz Postigo / WHO

27 September 2016 ¦ Geneva –– The World Health Organization (WHO) and Gilead Sciences have signed a new agreement that allows the pharmaceutical company to donate medicines for the treatment of visceral leishmaniasis.
Under the new 5-year collaboration and until 2021, Gilead Sciences have also agreed to provide financial assistance for the expansion of leishmaniasis surveillance and control.
Visceral leishmaniasis is endemic in more than 80 countries worldwide.

New leishmaniasis country profiles based on routine surveillance data

© Getty images

14 July 2016 | Geneva −−The World Health Organization (WHO) is leading an effort to leverage routine leishmaniasis surveillance data from 25 high-burden countries from WHO regions to create new profiles.

The data include breakdown of new, relapse and imported cases; populations at risk; control and surveillance (including latest national guidelines, number of leishmaniasis health facilities), diagnosis (such as number of people screened, proportion of positive rapid diagnostic tests) and treatment including initial cure and case-fatality rates.


Explore some of the issues surrounding visceral leishmaniasis in Africa and in India, and cutaneous leishmaniasis in South America. Watch the trailer of "A trilogy of injustice"

Photo gallery

Learn about the disease


Dr José Antonio Ruiz Postigo
Leishmaniasis Control Programme
+41 22 791 3870
+41 79 516 3882 (mobile)

Media contact:
Ashok Moloo
+41 22 791 1637
+41 79 540 50 86 (mobile)